[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology]

Ned Tijdschr Geneeskd. 2000 Oct 7;144(41):1979-80.
[Article in Dutch]
No abstract available

Publication types

  • Letter

MeSH terms

  • Diagnosis, Differential
  • Fluorodeoxyglucose F18*
  • Humans
  • Neoplasms / diagnostic imaging*
  • Neoplasms / metabolism
  • Radiopharmaceuticals*
  • Tomography, Emission-Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18